|
|
| Welcome to MyelomaLinks,
your monthly source of myeloma news,
research updates, clinical trials
and events of The Leukemia & Lymphoma
Society (LLS). For even more information,
regularly visit our Patient
Services and Disease
Information Web
sections. | |
 |
|
|
|
LLS
Features
::READ
MORE::
.....................................................................................................................................
Research
Roundup
::READ
MORE::
.....................................................................................................................................
IRC Question of
the Month
:: READ
MORE::
| |
|
Inspirational
Stories
 Learn how individuals touched
by blood cancer cope. LLS' LifeMosaic Web feature offers
hundreds of inspiring stories by patients and
families. Read them or submit your
own. |
Here to
Help
For
even more information, regularly visit the
LLS Web site,
www.LLS.org , where many of our
education programs are archived free of charge
for convenient access 24/7.
If you
haven't found what you're looking for in
MyelomaLinks, please call our
Information Resource Center (IRC) to speak with
trained information specialists. IRC staff are
available Monday through Friday, 9 a.m. to 6
p.m. ET, toll free at (800) 955-4572; email
infocenter@lls.org ; or click the "Live Patient
Help" button on the
www.LLS.org
homepage.
| |
|
|
Commentary
Certain cancer drugs can
cause heart problems. Learn what scientists
are doing to help patients. ::READ
MORE::
Clinical
Trials
We invite you to use our Clinical
Trial Service, a free and confidential
service that can help you find clinical trials
that meet your
needs.
You may also want to visit the
National Cancer Institute's Cancer
Trials Support Unit, providing resources and
information on Phase III cancer treatment trials
supported by the National Cancer
Institute.
::
SELECTED
TRIALS::
Newsfeeds &
Podcasts
Now
you can get RSS Feeds and Podcasts from LLS.
:: CLICK HERE TO SIGN
UP::
Free
eNewsletters
Free LLS
eNewsletters deliver the latest information on
research and treatment options, patient services
programs and fundraising events.
::
CLICK HERE TO SIGN
UP::
| | | |
| 
| | | |
|
|
|
Myeloma
Teleconference
LLS is pleased to present
the free telephone education program Stem Cell
Transplantation for Myeloma in the Era of Drug
Therapy, 2 p.m. - 3:30 p.m. ET, on
Tuesday, April 22. The
program will feature Edward A. Stadtmauer, M.D.,
professor of medicine, director, Bone Marrow and
Stem Cell Transplant Program and co-leader,
Hematologic Malignancies Program, Abramson
Cancer Center, the University of Pennsylvania.
Register online.
New
Podcasts
Too busy to
participate in a live LLS telephone education
program? Listen to an archived version by
adding our podcast feeds to your computer.
Podcast audio files are sent to
you automatically and feature leading
medical experts discussing a wide range of blood
cancer-related topics. There are many podcasts
to choose from, including seven new feeds
dedicated to recent teleconferences. Sign up
today. It's easy.
LLS
Blog
Check out
the new LLS blog for patients and
caregivers. The blog features top blood
cancer-related news and provide
personal stories from the folks
who are most affected by blood
cancers - patients and the ones who care for
them. The blog is completely interactive; you
can respond to people's posts. And while you're
there, visit our Cancer Centers
section.
Take Action
Clinical trials
are in danger because of poor insurance
reimbursements. Urge your member of
Congress to support HR
2676.
Myeloma
Booklets
LLS offers informative
booklets on myeloma in English
and Spanish.
Visit the Free
Materials Web page for access to all of
LLS' free disease- and treatment-related
materials.
Co-Pay
Assistance Program
Patients with
myeloma who have difficulty paying for or
simply cannot afford their prescription drug
co-pays or health insurance premiums can now
apply for assistance from LLS.
The Leukemia
& Lymphoma Society is committed to curing
blood cancers and helping patients and their
families. Learn the many ways you
can help advance the Society's
mission.
> Back to the
top | |
|
Phase I trial of oral
vorinostat (suberoylanilide hydroxamic acid,
SAHA) in patients with advanced multiple
myeloma ::READ MORE::
Sustained complete
remissions in multiple myeloma linked to
bortezomib in total therapy 3: comparison with
total therapy 2 ::READ MORE::
Improved survival in
multiple myeloma and the impact of novel
therapies ::READ MORE::
Thalidomide in
consecutive multiple myeloma patients:
single-center analysis on practical aspects,
efficacy, side effects and prognostic factors
with lower thalidomide doses ::READ MORE::
> Back to the
top | |
 We
invite you to use our Clinical
Trial Service, a free and confidential
service that can help you find clinical trials
that meet your needs. You may also want to visit
the National Cancer Institute's Cancer
Trials Support Unit , providing resources
and information on phase III cancer treatment
trials supported by the National Cancer
Institute.
Selected
Trials
CC-4047 and Dexamethasone in Treating
Patients with Relapsed or Refractory Multiple
Myeloma ::READ MORE::
Bortezomib, Cyclophosphamide, Dexamethasone
and Thalidomide in Treating Patients with Newly
Diagnosed, Previously Untreated Multiple
Myeloma ::READ MORE::
UARK 2006-32 Phase II Study of Rapidly
Recycled High Dose DTPACE ::READ MORE::
Phase III: Zoledronate with or without
Thalidomide in Treating Patients with Early
Stage Multiple Myeloma ::READ MORE::
Phase III: Lenalidomide in Treating Patients
Who Are Undergoing Autologous Stem Cell
Transplant for Multiple Myeloma ::READ MORE::
> Back to the
top
| |
IRC Question of
the Month: Integrative
Medicine
| 
Q: I've
heard about using integrative medicine as part
of cancer treatment. Can you tell me what this
is?
A: Integrative medicine
supports the use of some complementary and
alternative medicine (CAM) therapies - those
that have been found to be safe and effective -
in addition to conventional cancer therapies,
such as drug therapy, radiation therapy and
immunotherapy.
CAM therapies include support groups,
therapeutic massage, acupuncture, meditation,
yoga, art therapy and music therapy, among
others. There is no scientific evidence to date
that any CAM therapies will slow cancer
progression. However, some cancer patients say
that an integrative medicine approach helps
them to cope with their disease and
treatment, to feel better and to have a sense of
control over their health.
Studies are ongoing to evaluate CAM therapies
and to determine those that are safe and
effective for people living with leukemia,
lymphoma, myeloma, myelodysplastic
syndromes and other diseases. It is
important for patients to talk openly with their
treatment teams about any CAM therapies they are
currently using or considering using.
LLS has a fact sheet about integrative
medicine with information about CAM therapies,
including questions to ask your physician and
how to locate licensed IM and CAM providers. Click here to read a copy
online.
As
always, we encourage patients, their families
and caregivers to turn to the IRC for
information and support. IRC specialists are
available 9 a.m. to 6 p.m. ET. Call us with your
questions at (800)
955-4572.
> Back to the
top
| |
| | | |
|
|
 |
Supported by an
unrestricted
educational grant
from
 |
 |
| | | | | | | | |
